Latest Kaiser Health News Stories
Key House and Senate committees kick off hearings on drug prices, and patients’ families weigh in with tragic stories.
Emboldened by midterm election results and interest in possible presidential runs, Democrats are advancing a slew of new and old legislative proposals. It’s not yet clear, though, which if any could go the distance.
A radio report on an effort in California to hold doctors responsible when a patient overdoses on opioids. Doctors say it is unfair, but the state medical board defends the new project.
In a unique crackdown on what it sees as “excessive prescribing,” the state medical board is investigating hundreds of doctors whose patients ultimately died of opioid overdoses — whether or not the doctors prescribed the fatal medications.
A JAMA study looking at county-specific federal data finds that the more opioid-related marketing dollars spent in a county, the higher rates of doctors who prescribed those drugs, and ultimately, more overdose deaths.
Patients are often forced into using brand names because drug formularies favor them over cheaper competitors.
As drugmakers hike prices, interest to rein them in grows on Capitol Hill. Next week marks the anniversary of Roe v. Wade, the Supreme Court’s abortion decision, and both the House, whose leaders back abortion rights, and the Senate, controlled by abortion foes, are holding statement votes. And the government shutdown is still affecting health programs. Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Alice Ollstein of Politico join KHN’s Julie Rovner to discuss these issues.
While headlines continue to focus on the nation’s opioid crisis, a growing toll of overdoses and deaths related to methamphetamine use suggests this drug is making an under-the-radar comeback.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
In a recent study of patients treated by emergency medical responders in Oregon, black patients were 40 percent less likely to get pain medicine than their white peers. Why?
Loretta Boesing is on a mission to make sure prescription drugs delivered by mail are safe and effective. The life of her son — and others who order medicine by mail — could depend on it, she says.
Critics say patients are often misled by ads that advocate high-priced drugs or genetic tests.
A reporter with a serious peanut allergy explains what it is like to process news reports that tout new pharmaceutical products that might minimize the danger of accidental exposure.
The Food and Drug Administration is supposed to inspect all factories, foreign and domestic, that produce drugs for the U.S. market. But a KHN review of thousands of FDA documents — inspection records, recalls, warning letters and lawsuits — reveals how drugs that are poorly manufactured or contaminated can reach consumers.
The program that provides health care for about half of the U.S. territory’s population cannot afford to cover the drugs.
From Medicare dental coverage to drug prices to fetal tissue research, the panelists answer listeners’ questions. Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Paige Winfield Cunningham of The Washington Post join KHN’s Julie Rovner.